US 7,589,194 B2
	Crystalline k-252b, sodium salt, methanolate pentahydrate
Rodger F. Henry, Wildwood, Ill. (US)
Assigned to Abbott Laboratories, Abbott Park, Ill. (US)
Filed on Jan. 10, 2008, as Appl. No. 11/972,293.
Claims priority of provisional application 60/885016, filed on Jan. 16, 2007.
Prior Publication US 2008/0171868 A1, Jul. 17, 2008
Int. Cl. C07D 498/18 (2006.01)

U.S. Cl. 540—545

1 Claim

1. Crystalline (9S-(9α,10β,12α))-2,3,9,10,11,12-hexahydro-10-hydroxy-10-(carboxylate)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one methanolate pentahydrate characterized in the monoclinic crystal system and P21 space group, when measured at about −100° C. with Mo-Kα radiation, by lattice parameters a, b and c of 13.200 ű0.003 Å, 6.938 ű0.003 Å and 15.617 ű0.007 Å, respectively, and β of 104.674°±0.007.